Natural Products with Toll-Like Receptor 4 Antagonist Activity

被引:56
|
作者
Molteni, Monica [1 ]
Bosi, Annalisa [1 ]
Rossetti, Carlo [1 ]
机构
[1] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via Dunant 3, I-21100 Varese, Italy
关键词
D O I
10.1155/2018/2859135
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-Like Receptors (TLRs) are the innate immunity receptors that play an activating role when interacting with molecules released by bacteria and viruses (PAMPs, pathogen-associated molecular patterns) or with molecules released by injured cells and tissues (DAMPs, danger-associated molecular patterns). TLR triggering leads to the induction of proinflammatory cytokines and chemokines, driving the activation of both innate and adaptive immunity. In particular, Toll-Like Receptor 4 (TLR4) has been described to be involved in the inflammatory processes observed in several pathologies (such as ischemia/reperfusion injury, neuropathic pain, neurodegenerative diseases, and cancer). Molecules obtained by natural sources have been discovered to exert an anti-inflammatory action by targeting TLR4 activation pathways. This review focuses on TLR4 antagonists obtained from bacteria, cyanobacteria, and plants.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Bartonella quintana lipopolysaccharide is a natural antagonist of toll-like receptor
    Popa, Calin
    Abdollahi-Roodsaz, Shahla
    Joosten, Leo A. B.
    Takahashi, Nozomi
    Sprong, Tom
    Matera, Giovanni
    Liberto, Maria Carla
    Foca, Alfredo
    van Deuren, Marcel
    Kullberg, Bart Jan
    van den Berg, Wim B.
    van der Meer, Jos W. M.
    Netea, Mihai G.
    INFECTION AND IMMUNITY, 2007, 75 (10) : 4831 - 4837
  • [2] Modulation of Toll-like receptor signaling in innate immunity by natural products
    Chen, Luxi
    Yu, Jianhua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 37 : 65 - 70
  • [3] Toll-like receptor 2 and toll-like receptor 4 expression in human adrenals
    Bornstein, SR
    Schumann, RR
    Rettori, V
    McCann, SM
    Zacharowski, K
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (07) : 470 - 473
  • [4] An anti-asthmatic activity of natural Toll-like receptor-4 antagonist in OVA-LPS-induced asthmatic rats
    Thakur, Vandana R.
    Beladiya, Jayesh V.
    Chaudagar, Kiranj K.
    Mehta, Anita A.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2018, 45 (11): : 1187 - 1197
  • [5] Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis
    Tidswell, Mark
    LaRosa, Steven P.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (05) : 507 - 520
  • [6] Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides
    Tapping, RI
    Akashi, S
    Miyake, K
    Godowski, PJ
    Tobias, PS
    JOURNAL OF IMMUNOLOGY, 2000, 165 (10): : 5780 - 5787
  • [7] Toll-like receptor 4 in atherosclerosis
    Li, Hongli
    Sun, Baogui
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (01) : 88 - 95
  • [8] Toll-like receptor 4 and atherogenesis
    Kiechl, S
    Wiedermann, CJ
    Willeit, J
    ANNALS OF MEDICINE, 2003, 35 (03) : 164 - 171
  • [9] Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease
    Moens, Leen
    Verhaegen, Jan
    Pierik, Marie
    Vermeire, Severine
    De Boeck, Kris
    Peetermans, Willy E.
    Bossuyt, Xavier
    MICROBES AND INFECTION, 2007, 9 (01) : 15 - 20
  • [10] Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cells
    Spitzer, JH
    Visintin, A
    Mazzoni, A
    Kennedy, MN
    Segal, DM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (04) : 1182 - 1187